NCT00355719View on ClinicalTrials.gov

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
HIV Infections
Interventions
DRUG

Atazanavir (Reyataz)

Atazanavir (Reyataz): capsules 150 mg (2 capsules/24h)

DRUG

Ritonavir (Norvir)

Ritonavir (Norvir): capsules 100 mg (1 capsule/24h)

DRUG

Nevirapine (Viramune)

Nevirapine (Viramune): tablets 200 mg (1 tablet/12h\*)

Trial Locations (2)

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08370

Hospital Sant Jaume de Calella, Calella

All Listed Sponsors
collaborator

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

collaborator

Hospital San Jaime de Calella

UNKNOWN

lead

Germans Trias i Pujol Hospital

OTHER

NCT00355719 - Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients | Biotech Hunter | Biotech Hunter